10/19/2026
FDA seeks input on ibogaine trial design, advances psychedelic framework
FDA's request for ibogaine trial input marks a step in psychedelic drug regulation.
Topic archive
2 stories
10/19/2026
FDA's request for ibogaine trial input marks a step in psychedelic drug regulation.
10/6/2026
Request focuses on safety, dosing, and oversight for early-phase trials.